WAM
GCTK icon

Warberg Asset Management’s GlucoTrack GCTK Stock Holding History

Warberg Asset Management’s Portfolio GCTK Stock Details GCTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-5
Closed -$7.88K – 246
2023
Q3 		$7.88K Hold
5
– – ﹤0.01% 186
2023
Q2 		$10.4K Buy
+5
New +$18K ﹤0.01% 179

Other funds holding GCTK

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
AF
Alerus Financial Grand Forks, North Dakota $2.02B AUM 26.03% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BFM
Boston Financial Management Boston, Massachusetts $3.31B AUM 19.4% 1-Year Est. Return
AWM
Accurate Wealth Management Wesley Chapel, Florida $1.05B AUM 30.92% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Warberg Asset Management's GCTK Position: Q4 2023 in Review

Warberg Asset Management sold out of GlucoTrack (GCTK) in Q4 2023, closing a stake of 5 shares — an estimated $7.88K sold.

Warberg Asset Management first reported a position in GCTK in Q2 2023 and held it in 2 quarters. The position peaked at $10.4K in Q2 2023. 8 funds tracked by Wall St. Rank hold GCTK as of Q4 2023.

  • Warberg Asset Management reported no remaining GlucoTrack position as of Q4 2023 after selling out during the quarter.
  • Warberg Asset Management sold 5 GlucoTrack shares in Q4 2023, an estimated $7.88K.
  • Warberg Asset Management first reported a position in GlucoTrack in Q2 2023 and held it in 2 quarters.
  • Warberg Asset Management's GlucoTrack position peaked at $10.4K in Q2 2023.
  • 8 funds tracked by Wall St. Rank held GlucoTrack as of Q4 2023.

Based on Warberg Asset Management's 13F filing for Q4 2023, filed 7 Feb 2024.